Omega-3 Fatty Acid Ethyl-Eicosapentaenoate Attenuates IL-1β-Induced Changes in Dopamine and Metabolites in the Shell of the Nucleus Accumbens: Involved with PLA2 Activity and Corticosterone Secretion
Authors:
- 14 June 2006
- journal article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 32 (3) , 736-744
Abstract
Previously, we have reported that interleukin-1 (IL-1) induces changes in dopaminergic (DA) and serotonergic systems in the core of nucleus accumbens (NAc). We have also demonstrated that n-3 fatty acid ethyl-eicosapentaenoate (EPA) can significantly reduce stress and anxiety-like behaviors, corticosterone concentration and peripheral inflammatory response induced by IL-1 administration. Compared to the core, the shell is involved more in emotion, stress and psychiatric diseases. However, the relationship between inflammation and the functions of DA system in the shell has not been studied. Since phospholipase (PL) A2 is a key enzyme in arachidonic acid (AA)- eicosanoids-prostaglandin (PG)E2 pathway, and the change in NAc dopaminergic system has been associated with glucocorticoid stimulation, therefore, the hypotheses of this study are (1) that IL-1 induced changes in DA neurotransmission in the shell may be through PLA2-PGE2-corticosterone pathway; (2) EPA may attenuate IL-1 effects via inhibiting PLA2 activities, which blocks PGE2 stimulation of corticosterone. Using an in vivo microdialysis method, the present study showed that IL-1 administration significantly increased extracellular levels of DA, and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the shell of the NAc. IL-1 also increased blood concentration of corticosterone and PGE2, and increased the activities of cytosolic and sectory of PLA2. IL-1-induced changes were significantly attenuated by EPA treatment. Furthermore, glucorcoticoid receptor antagonist mifepristone (RU486) pretreatment significantly blocked IL-1-induced changes in DA and metabolites. Qquinacrine, a PLA2 antagonist significantly blocked IL-1 induced increase in PGE2 and corticosterone concentrations. These results demonstrated the hypotheses that IL-1 effects may be via PLA2-PGE2-corticosterone pathway and EPA attenuated IL-1 effects may be through the suppression of PLA2 expression, which then reduced PGE2 synthesis and corticosterone secretion.Keywords
This publication has 70 references indexed in Scilit:
- Essential fatty acids and phospholipase A2 in autistic spectrum disordersProstaglandins, Leukotrienes and Essential Fatty Acids, 2004
- The expression of brain cyclooxygenase‐2 is down‐regulated in the cytosolic phospholipase A2 knockout mouseJournal of Neurochemistry, 2003
- Stressor controllability modulates stress‐induced serotonin but not dopamine efflux in the nucleus accumbens shellSynapse, 2003
- In Altering the Release of Glucocorticoids, Ketorolac Exacerbates the Effects of Systemic Immune Stimuli on Expression of Proinflammatory Genes in the BrainEndocrinology, 2002
- Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changesBrain, Behavior, and Immunity, 2002
- Low Arachidonic Acid Rather than α-Tocopherol Is Responsible for the Delayed Postnatal Development in Offspring of Rats Fed Fish Oil Instead of Olive Oil during Pregnancy and LactationThe Journal of Nutrition, 2000
- Glucocorticoid receptor antagonist RU 486 treatment reduces periodontitis in Fischer 344 ratsJournal of Periodontal Research, 2000
- Synergistic Effects of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α Central Monoamine, Corticosterone, and Behavioral VariationsNeuropsychopharmacology, 2000
- The dopaminergic hyper‐responsiveness of the shell of the nucleus accumbens is hormone‐dependentEuropean Journal of Neuroscience, 2000
- The biological, social and clinical bases of drug addiction: commentary and debatePsychopharmacology, 1996